In cultured rat CF, the KATP activator nicorandil attenuated Ang II-induced proliferation and endothelin-1 expression, an effect that was reversed by treatment of CF with glibenclamide, further indicating that KATP channels act to oppose the MF phenotype [271]. Here, EDN1 is linked to cystic fibrosis.